Cargando…

The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias.

The 5 membered SET and MYND Domain-containing lysine methyltransferase (SMYD) family plays pivotal roles in development and proliferation. Initially characterized within the cardiovascular system, one such member, SMYD2, has been implicated as an oncogene in leukemias deriving from flawed hematopoie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Mark A., Edwards, Melissa A., Alshiraihi, Ilham, Geng, Huimin, Dekker, Joseph D., Tucker, Haley O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183909/ https://www.ncbi.nlm.nih.gov/pubmed/32115575 http://dx.doi.org/10.1038/s41435-020-0094-8

Ejemplares similares

The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo
por: Edwards, Melissa A., et al.
Publicado: (2020)

Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors
por: Jarrell, Dillon K., et al.
Publicado: (2021)

Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation
por: Zhu, Li, et al.
Publicado: (2023)

SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
por: Zipin-Roitman, Adi, et al.
Publicado: (2017)

Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
por: Talibov, Vladimir O., et al.
Publicado: (2021)

Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
por: Padilla, Alyssa, et al.
Publicado: (2023)

Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
por: Reynoird, Nicolas, et al.
Publicado: (2016)

Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
por: Li, Linda Xiaoyan, et al.
Publicado: (2018)

Exploration of the Substrate Preference of Lysine Methyltransferase SMYD3 by Molecular Dynamics Simulations
por: Sun, Jixue, et al.
Publicado: (2019)

Molecular Dynamics Simulation Reveals Correlated Inter-Lobe Motion in Protein Lysine Methyltransferase SMYD2
por: Spellmon, Nicholas, et al.
Publicado: (2015)

Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization
por: Yoshioka, Yuichiro, et al.
Publicado: (2017)

Lysine methyltransferase SMYD2 inhibits antiviral innate immunity by promoting IRF3 dephosphorylation
por: Wu, Jiacheng, et al.
Publicado: (2023)

LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
por: Nguyen, Hannah, et al.
Publicado: (2015)

Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non‐Histone Substrates
por: Weirich, Sara, et al.
Publicado: (2019)

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
por: Foreman, Kenneth W., et al.
Publicado: (2011)

The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11
por: Boehm, Daniela, et al.
Publicado: (2023)

Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic
por: Alshiraihi, Ilham M., et al.
Publicado: (2021)

Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray
por: Stewart, M. David, et al.
Publicado: (2016)

Why are so many MLL lysine methyltransferases required for normal mammalian development?
por: Crump, Nicholas T., et al.
Publicado: (2019)

Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019)

The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production
por: Eberle, Carol-Ann, et al.
Publicado: (2014)

Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
por: Eggert, Erik, et al.
Publicado: (2016)

In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells
por: Alshiraihi, Ilham M., et al.
Publicado: (2020)

Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
por: Brown, Mark A, et al.
Publicado: (2006)

Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN()()
por: Nakakido, Makoto, et al.
Publicado: (2015)

The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development
por: Fittipaldi, Raffaella, et al.
Publicado: (2021)

Histone methyltransferase Smyd3 is a new regulator for vascular senescence
por: Yang, Di, et al.
Publicado: (2020)

The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network
por: Codato, Roberta, et al.
Publicado: (2019)

C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis
por: Brown, Mark A., et al.
Publicado: (2015)

SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters
por: Zhang, Yanjun, et al.
Publicado: (2022)

Lysine Ethylation by Histone Lysine Methyltransferases
por: Al Temimi, Abbas H. K., et al.
Publicado: (2019)

Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase
por: Pereira, David, et al.
Publicado: (2020)

Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022)

STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression
por: Ma, Wei, et al.
Publicado: (2018)

Smyd1 Facilitates Heart Development by Antagonizing Oxidative and ER Stress Responses
por: Rasmussen, Tara L., et al.
Publicado: (2015)

SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1
por: Yoshioka, Yuichiro, et al.
Publicado: (2016)

Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity
por: Su, Zhenghua, et al.
Publicado: (2022)

Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
por: Su, Haibi, et al.
Publicado: (2022)

The SMYD1 and skNAC transcription factors contribute to neurodegenerative diseases
por: Mayfield, R. Dayne, et al.
Publicado: (2020)

Loss of SMYD1 Results in Perinatal Lethality via Selective Defects within Myotonic Muscle Descendants
por: Rasmussen, Tara L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h5uql2iooc8g1vekj86hrmag61